or Try an Advanced Search...

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    F 88.50 0.63% 0.55
    BNTX closed up 0.85 percent on Monday, April 29, 2024, on 66 percent of normal volume.
    Earnings due: May 6
    *** please verify all earnings dates ***
    8 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.63%
    Gapped Up Strength 1.48%
    20 DMA Resistance Bearish 0.47%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.47%
    Inside Day Range Contraction 0.47%
    20 DMA Resistance Bearish 0.01%
    MACD Bullish Signal Line Cross Bullish 0.01%
    Up 3 Days in a Row Strength 0.01%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.56%
    Oversold Stochastic Weakness 0.56%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA less than a minute ago
    20 DMA Support less than a minute ago
    20 DMA Resistance about 18 hours ago
    Up 1 ATR about 23 hours ago
    60 Minute Opening Range Breakout about 23 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Biomarkers Allergy Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 27 WHO picks JN.1 variant for next set of COVID vaccines
    Apr 25 What's Going On With Pfizer Stock On Thursday?
    Apr 25 Wall Street plunges after US inflation shock
    Apr 25 Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines
    Apr 25 UPDATE 2-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
    Apr 25 GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
    Apr 23 Pfizer vs Moderna battle over COVID vaccine patents begins in UK
    Apr 22 25 Richest Billionaires in Healthcare Industry
    Apr 22 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
    Apr 17 Assessing BioNTech: Insights From 11 Financial Analysts
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 125.83
    52 Week Low 85.2129
    Average Volume 615,378
    200-Day Moving Average 100.80
    50-Day Moving Average 90.68
    20-Day Moving Average 88.22
    10-Day Moving Average 87.22
    Average True Range 2.18
    RSI (14) 45.95
    ADX 10.52
    +DI 22.08
    -DI 20.05
    Chandelier Exit (Long, 3 ATRs) 87.32
    Chandelier Exit (Short, 3 ATRs) 91.93
    Upper Bollinger Bands 91.43
    Lower Bollinger Band 85.00
    Percent B (%b) 0.46
    BandWidth 7.28
    MACD Line -1.13
    MACD Signal Line -1.30
    MACD Histogram 0.1667
    Fundamentals Value
    Market Cap 20.91 Billion
    Num Shares 238 Million
    EPS 12.15
    Price-to-Earnings (P/E) Ratio 7.24
    Price-to-Sales 3.38
    Price-to-Book 1.03
    PEG Ratio 0.04
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 91.73
    Resistance 3 (R3) 91.84 90.68 91.10
    Resistance 2 (R2) 90.68 89.72 90.63 90.89
    Resistance 1 (R1) 89.32 89.13 90.00 89.21 90.68
    Pivot Point 88.16 88.16 88.51 88.11 88.16
    Support 1 (S1) 86.80 87.20 87.48 86.69 85.22
    Support 2 (S2) 85.64 86.61 85.59 85.01
    Support 3 (S3) 84.28 85.64 84.80
    Support 4 (S4) 84.17